KRQ 10071
Latest Information Update: 24 May 2001
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Class Antibacterials
- Mechanism of Action DNA gyrase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 24 May 2001 No-Development-Reported for Bacterial infections in South Korea (Unknown route)
- 27 Nov 1997 New profile
- 27 Nov 1997 Preclinical development for Bacterial infections in South Korea (Unknown route)